Litcius/Paper detail

MNK2 governs the macrophage antiinflammatory phenotype

Margarita Bartish, Dongmei Tong, Yangxun Pan, Majken Wallerius, Hui Liu, Johannes Ristau, Sabrina de Souza Ferreira, Tatjana Wallmann, Vincent van Hoef, Laìa Masvidal, Thomas Kerzel, Anne-Laure Joly, Christophe Gonçalves, Samuel E.J. Preston, Talin Ebrahimian, Christina Seitz, Jonas Bergh, Kristian Pietras, Stéphanie Lehoux, Luigi Naldini, John Andersson, Mario Leonardo Squadrito, Sonia V. del Rincón, Ola Larsson, Charlotte Rolny

2020Proceedings of the National Academy of Sciences34 citationsDOIOpen Access PDF

Abstract

Significance The tumor-associated macrophage (TAM) phenotype is continuously modulated during tumor progression to facilitate immune escape. Yet, how gene expression programs control TAM phenotypes during this process is largely unknown. Here we show that, during acquisition of a protumor phenotype, gene expression in TAMs is predominantly modulated via selective changes in mRNA translation rather than changes in mRNA abundance. Detailed studies pinpointed augmented activity of MNK2, which phosphorylates eIF4E and thereby modulates mRNA translation, as required for the antiinflammatory macrophage phenotype. Accordingly, suppression of MNK2 reeducated antiinflammatory macrophages toward a proinflammatory phenotype with the ability to activate CD8 + T cells.

Topics & Concepts

EIF4EBiologyCell biologyPI3K/AKT/mTOR pathwayTranslation (biology)PhenotypeGene expressionImmune systemTumor microenvironmentCancer researchProinflammatory cytokineSignal transductionInflammationMessenger RNAGeneImmunologyGeneticsImmune Cell Function and InteractionImmune cells in cancerPhagocytosis and Immune Regulation